Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy.
Minyan ChenShengmei LiMeng HuangJingjing GuoXuan HuangWenhui GuoLili ChenYuxiang LinLisa JacobsChuan WangFangmeng FuPublished in: Breast cancer research and treatment (2022)
In biopsy-proven node-positive breast cancer treated with NAC, using a flowchart to optimize patient selection reduces the FNR of single-tracer (methylene-blue-dye) guided SLNB.